β-Cyclodextrin modified graphene oxide–magnetic nanocomposite for targeted delivery and pH-sensitive release of stereoisomeric anti-cancer drugs

Abstract

β-Cyclodextrin modified graphene oxide–magnetic (MGC) nanocomposite as an innovative drug carrier was the first to be developed <italic>via</italic> an effective layer-by-layer-assembly method.